NasdaqGS:XRAYMedical Equipment
DENTSPLY SIRONA (XRAY): Evaluating Value After CEO’s Strategy Shift Towards Execution and Digital Integration
If you have been following DENTSPLY SIRONA (XRAY), the company’s latest comments may have given you a reason to look twice at the stock. The new CEO has signaled a clear pivot in strategy, moving away from making disruptive changes and instead doubling down on operational execution. That means focusing on integrated digital workflows and streamlining the customer experience, especially across product lines like EDS and Wellspect. Some believe this approach could set the stage for a steadier,...